Michael I. Okkonen


Michael I. Okkonen


Brussels | 480 Avenue Louise, Box 13A, Brussels, Belgium 1050
+32 2 535 5416 | +32 2 535 5400

Frankfurt | Tower 185, Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, Germany 60327
+49 69 7706194244 | +49 69 77 06 19 19


Michael Okkonen focuses his practice on all aspects of EU competition law, with a particular focus on complex merger control proceeding as well as cartel and abuse of dominance matters. He also advises on issues relating to the control of foreign direct investment (FDI).

Michael has experience advising clients across a broad range of sectors, including chemicals, consumer products, manufacturing and pharmaceuticals.

Prior to joining Dechert, Michael worked at the European Commission (DG Competition) and a law firm in Finland.

Michael regularly publishes on competition law topics.

  • American Express Global Business Travel on its investments, including the acquisition of Hogg Robinson Group and DER Touristik Business Travel Division.
  • Cathay Capital on its Investment in Cenexi Group.
  • Cerberus and PaxVax on Sale of PaxVax to Emergent BioSolutions for US $270 million.
  • Chatchaval Jiaravanon on its acquisition of Fortune Media Brand from Meredith Corporation Limited for US $150 million. 
  • Conterra on minority investment in Fiera Infastructure Inc. from Court Square Capital Partners and other equity holders.
  • Court Square Capital Partners on its investment in Getaroom.
  • Crown Holdings, Inc., a global leader in consumer packaging, in connection with its proposed acquisition of Signode Industrial Group Holdings (Bermuda) Ltd., a leading global provider of transit packaging systems and solutions, from The Carlyle Group, for US $3.9 billion.  Mr. Okkonen helped Crown to secure regulatory clearance from the European Commission, Brazil’s Administrative Council for Economic Defense (CADE), and many other international authorities.
  • Differential Brands Group Inc.’s acquisition of Global Brands Group’s North American Division for US $1.2 billion.
  • Egalet in its acquisition of four non-narcotic pain products from Iroko Pharmaceuticals.
  • Encompass Digital Media (a portfolio company of Court Square Capital Partners) on their acquisition of Babcock Media Services Limited, a specialist telecommunications and satellite network services provider. 
  • FMC Corporation on the sale of its Health and Nutrition business to DowDuPont in exchange for portions of DuPont’s global crop protection business, which were divested as a condition of DuPont’s merger with Dow valued at US $145 billion. Mr. Okkonen helped FMC secure regulatory clearance from the European Commission, Brazil’s Administrative Council for Economic Defense (CADE), and many other international authorities.
  • Ipsen in its acquisition of the global oncology assets of Merrimack Pharmaceuticals, including its key marketed product ONIVYDE®, for up to US $1 billion. 
  • J.H. Whitney in various acquisitions.
  • Kofax on US $1 billion sale to Lexmark.
  • Lazada on US $1 billion sale to Alibaba.
  • M1 Fashion and L Capital Asia on Pepe Jeans Group Acquisition before the EU Commission.
  • MSD Partners in its acquisition of Hayward Industries in Partnership with CCMP Capital Advisors, Alberta Investment Management Corp. and Ring Container Technologies.
  • OCI Enterprises Inc. in sale of OCI Resources LP Interests to Park Holding A.S. of Ciner Group.
  • One Equity Partners and PeroxyChem on the potential sale of the latter to Evonik Industries for US $625 million.  Mr. Okkonen helped One Equity Partners and PeroxyChem secure regulatory clearance from the European Commission and many other international authorities.  
  • One Equity Partners on the acquisition of the MERA group, a custom software developments services provider. 
  • Osgood Capital and Cyprium Partners in their joint acquisition of the Uniloy Blow Molding business from Milacron Holdings Corp. 
  • Ritchie Bros. on US$758.5 million Acquisition of IronPlanet.
  • Rocket Software in US $2 Billion Investment by Bain Capital Private Equity.
  • Shanghai Shenda in Formation of Joint Venture with IAC in Automotive Soft Trim and Acoustics Supply Business.
  • SK Siltron on its purchase of Silicon Carbide (SiC) Wafer business for US $450 million from DuPont.
  • Tech Mahindra on US $240 Million Acquisition of Lightbridge Communications Corporation.
  • A major US pharmaceutical supplier against a takeover by another US pharmaceutical company.
  • University of Warwick, LL.B. Law (Hons), 2008
  • College of Law, Legal Practice Course, 2009
  • College of Europe, LL.M., European Legal Studies, 2012
  • King’s College London, Postgraduate Diploma in Legal Practice, Economics in Competition Law, 2017
  • England and Wales
  • New York
  • Brussels
External Articles
  • Minimising the risk of breaching antitrust rules in Research and Development (R&D)  collaboration, Practical Law (December 1, 2019)
  • Pharmaceutical Antitrust: United Kingdom Chapter, Getting The Deal Through (September 2019)
  • Crossed Wires: Private Equity Firms not Immune to Antitrust Risk, International Financial Law Review (February 26, 2019)
  • Recent EU Fines for Resale Price Maintenance Are Symptoms of Broader Challenges Faced by Today's Consumer-Goods Manufacturers, European Competition Law Review (November 2018)  
  • English
  • French
  • Russian
  • Finnish
  • Spanish